Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH
Key decision factors
- Response deadline
- Sep 15, 2026 3:00 PM EDT
- Posted
- Sep 8, 2026 12:00 AM EDT
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- PSC
- Q301 — Reference Laboratory Testing
- Place of performance
- Baltimore, Maryland
- Current status
- Closed
Notice details
- Official status
- Closed
- Normalized group
- Other
- Notice ID
- c0fa055913f647c4b3262722fd66122f
- Solicitation number
- NOI-PCA-NIDA-09054
Description
Displayed as sanitized plain text from SAM.gov. Retrieved Sep 9, 2026 10:23 PM EDT.
Attachments
2 attachments reported by SAM.gov
Files are hosted by SAM.gov. Open the official notice to review and download them.
Contacts
Personalized relevance
Would this fit your company?
Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.
Create Free AccountPursuit risk (separate from your match score)
Document analysis pending
Some solicitation documents have not been analyzed yet. Additional restrictions may still be present.
Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.